NCT00188773View on ClinicalTrials.gov

Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

January 31, 2008

Conditions
Insulin Resistance Syndrome XPancreatic Beta Cell Function
Interventions
DRUG

N-acetylcysteine, intralipid, heparin

One visit subject will receive N-acetylcysteine plus intralipid and heparin, another visit n-acetylcyksteine plus saline, another visit intralipid and heparin and another visit saline alone

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT00188773 - Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion | Biotech Hunter | Biotech Hunter